Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin's Lymphoma(NHL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT01961063
What this trial is testing

Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Non-Hodgkin LymphomaAIDS-related Plasmablastic LymphomaAIDS-related Primary Effusion Lymphoma+1 more
City of Hope Medical Center 3
Not applicableWithdrawnNCT04293900
What this trial is testing

Diet, Physical Activity and Body Composition Changes During R-CHOP

Who this might be right for
Non-Hodgkin LymphomaDLBCLDiffuse Large B Cell Lymphoma
George Washington University
Testing effectiveness (Phase 2)Ended earlyNCT04305444
What this trial is testing

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Who this might be right for
Relapsed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaDiffuse Large B Cell Lymphoma+2 more
Zhejiang DTRM Biopharma 55
Early research (Phase 1)Study completedNCT02432235
What this trial is testing

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma
ADC Therapeutics S.A. 133
Early research (Phase 1)Study completedNCT00002750
What this trial is testing

Melphalan in Patients With Neoplastic Meningitis

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more
Duke University 6
Testing effectiveness (Phase 2)Ended earlyNCT00335140
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 26
Early research (Phase 1)Study completedNCT03527147
What this trial is testing

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

Who this might be right for
NHLDLBCLNon-hodgkin's Lymphoma+1 more
Acerta Pharma BV 30
Post-approval studies (Phase 4)UnknownNCT04134247
What this trial is testing

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Who this might be right for
Relapsed/Refractory Non-Hodgkin's Lymphoma
Shandong Provincial Hospital 120
Early research (Phase 1)Study completedNCT01351935
What this trial is testing

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
B Cell Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia
Celgene 113
Testing effectiveness (Phase 2)Looking for participantsNCT06784726
What this trial is testing

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+9 more
University of Washington 27
Large-scale testing (Phase 3)Ended earlyNCT05664217
What this trial is testing

NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Non-Hodgkin LymphomaRelapsed/Refractory Diffuse Large B-cell Lymphoma
Nektar Therapeutics 15
Testing effectiveness (Phase 2)Looking for participantsNCT06021678
What this trial is testing

Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma

Who this might be right for
CD20-positive Non-Hodgkin Lymphoma
Guangzhou Excelmab Inc. 415
Testing effectiveness (Phase 2)Study completedNCT00094848
What this trial is testing

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
Human Genome Sciences Inc.
Testing effectiveness (Phase 2)UnknownNCT04089215
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 82
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Not applicableStudy completedNCT02919670
What this trial is testing

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 114
Not applicableLooking for participantsNCT03131531
What this trial is testing

Bergamo Lymphoid Cancer Registry

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaMyeloma
A.O. Ospedale Papa Giovanni XXIII 6,000
Not applicableNo Longer AvailableNCT00720603
What this trial is testing

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00026351
What this trial is testing

Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Next Page